Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients.

MLA

Lee, Young Ki, et al. “Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients.” Diabetes & Metabolism Journal, vol. 37, no. 6, Dec. 2013, pp. 465–74. EBSCOhost, https://doi.org/10.4093/dmj.2013.37.6.465.

APA

Lee, Y. K., Song, S. O., Kim, K. J., Cho, Y., Choi, Y., Yun, Y., Lee, B.-W., Kang, E.-S., Cha, B. S., & Lee, H. C. (2013). Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients. Diabetes & Metabolism Journal, 37(6), 465–474. https://doi.org/10.4093/dmj.2013.37.6.465

Chicago

Lee, Young Ki, Sun Ok Song, Kwang Joon Kim, Yongin Cho, Younjeong Choi, Yujung Yun, Byung-Wan Lee, Eun-Seok Kang, Bong Soo Cha, and Hyun Chul Lee. 2013. “Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients.” Diabetes & Metabolism Journal 37 (6): 465–74. doi:10.4093/dmj.2013.37.6.465.